This podcast features a panel discussion from the 2026 Chief Medical Officer Summit 360°, with biotech CMOs and representatives from pharma companies. Together, they address how interactions around partnerships or acquisitions differ from those of investment from biotech companies and how CMOs can support those conversations. This includes:
How pharma companies analyze potential partners
What biotech companies can do to best partner with pharma
How the CMO fits into various phases of transactions
Appreciating how different c-suite colleagues and direct reports experience these transactions
The different pharma teams CMOs will interact with
Common challenges to partnerships and how to pre-empt them
What happens after the acquisition
To learn more about the Chief Medical Officer Summit 360°, please visit CMOSummit360.com.
Podden och tillhörande omslagsbild på den här sidan tillhör
Conference Forum. Innehållet i podden är skapat av Conference Forum och inte av,
eller tillsammans med, Poddtoppen.
